Published in PLoS One on May 20, 2010
The interaction between training and plasticity in the poststroke brain. Curr Opin Neurol (2013) 1.28
On the importance of long-term functional assessment after stroke to improve translation from bench to bedside. Exp Transl Stroke Med (2011) 0.96
Transmembrane semaphorins: Multimodal signaling cues in development and cancer. Cell Adh Migr (2016) 0.76
Current drug design to target the Semaphorin/Neuropilin/Plexin complexes. Cell Adh Migr (2016) 0.75
Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science (1996) 5.57
Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell (2002) 4.87
Use-dependent alterations of movement representations in primary motor cortex of adult squirrel monkeys. J Neurosci (1996) 4.10
Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature (2001) 3.07
The semaphorins. Genome Biol (2006) 2.73
Reorganization of movement representations in primary motor cortex following focal ischemic infarcts in adult squirrel monkeys. J Neurophysiol (1996) 2.65
Clinical gene therapy using recombinant adeno-associated virus vectors. Gene Ther (2008) 2.54
Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci (2005) 2.17
Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp Neurol (2005) 2.08
AAV-mediated hippocampal expression of short and long Homer 1 proteins differentially affect cognition and seizure activity in adult rats. Mol Cell Neurosci (2005) 1.92
Reorganization of remote cortical regions after ischemic brain injury: a potential substrate for stroke recovery. J Neurophysiol (2003) 1.89
Neurogenesis after ischaemic brain insults. Curr Opin Neurobiol (2003) 1.80
Short and long-term motor skill learning in an accelerated rotarod training paradigm. Neurobiol Learn Mem (2004) 1.72
The transmembrane semaphorin Sema6A controls cerebellar granule cell migration. Nat Neurosci (2005) 1.37
Role of semaphorins in the adult nervous system. Prog Neurobiol (2003) 1.32
AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. Mol Ther (2008) 1.31
Emerging roles for semaphorins in neural regeneration. Brain Res Brain Res Rev (2001) 1.29
Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. Neural Dev (2008) 1.24
A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. J Neurochem (2004) 1.04
The transmembrane protein semaphorin 6A repels embryonic sympathetic axons. J Neurosci (2000) 0.98
Canavan disease: a white matter disorder. Ment Retard Dev Disabil Res Rev (2006) 0.94
Photochemically induced cortical infarction in the rat. 1. Time course of hemodynamic consequences. J Cereb Blood Flow Metab (1986) 0.92
Expressions of neuropilin-1, neuropilin-2 and semaphorin 3A mRNA in the rat brain after middle cerebral artery occlusion. Brain Res (2001) 0.92
Cloning and expression of a novel murine semaphorin with structural similarity to insect semaphorin I. Mol Cell Neurosci (1997) 0.89
Plasticity-associated molecular and structural events in the injured brain. J Neuropathol Exp Neurol (2002) 0.89
Adeno-associated virus (AAV)-mediated suppression of Ca2+/calmodulin kinase IV activity in the nucleus accumbens modulates emotional behaviour in mice. BMC Neurosci (2007) 0.86
Long-term gene expression changes in the cortex following cortical ischemia revealed by transcriptional profiling. Exp Neurol (2006) 0.79
The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron (2006) 4.12
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med (2003) 3.57
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest (2005) 3.22
Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol (2013) 2.61
Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke (2007) 2.54
Synaptic inhibition in the olfactory bulb accelerates odor discrimination in mice. Neuron (2010) 2.40
Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial. Stroke (2013) 2.36
Homer2 is necessary for EtOH-induced neuroplasticity. J Neurosci (2005) 2.17
Mitochondrial CB₁ receptors regulate neuronal energy metabolism. Nat Neurosci (2012) 2.15
Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke (2008) 1.93
Homer proteins regulate sensitivity to cocaine. Neuron (2004) 1.83
Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: an analysis of the Virtual International Stroke Trials Archive (VISTA) database. Stroke (2012) 1.79
Sindbis vector SINrep(nsP2S726): a tool for rapid heterologous expression with attenuated cytotoxicity in neurons. J Neurosci Methods (2004) 1.79
Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking. J Neurosci (2010) 1.76
Combined laparoscopic-endoscopic resections of colorectal polyps: 10-year experience and follow-up. Surg Endosc (2009) 1.74
Close-field electroporation gene delivery using the cochlear implant electrode array enhances the bionic ear. Sci Transl Med (2014) 1.57
Loss of Dickkopf-1 restores neurogenesis in old age and counteracts cognitive decline. Cell Stem Cell (2013) 1.53
Comparison between breast volume measurement using 3D surface imaging and classical techniques. Breast (2006) 1.51
Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab (2005) 1.49
Binge drinking upregulates accumbens mGluR5-Homer2-PI3K signaling: functional implications for alcoholism. J Neurosci (2009) 1.47
Production and titering of recombinant adeno-associated viral vectors. J Vis Exp (2011) 1.41
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain (2008) 1.40
A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab (2007) 1.39
Neuroprotection for ischaemic stroke: translation from the bench to the bedside. Int J Stroke (2012) 1.37
Synaptic scaffolding protein Homer1a protects against chronic inflammatory pain. Nat Med (2006) 1.35
AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. Mol Ther (2008) 1.31
Dilemmas in the management of atrial fibrillation in chronic kidney disease. J Am Soc Nephrol (2008) 1.30
Rapid, reproducible transduction of select forebrain regions by targeted recombinant virus injection into the neonatal mouse brain. J Neurosci Methods (2009) 1.29
The efficacy of erythropoietin and its analogues in animal stroke models: a meta-analysis. Stroke (2009) 1.29
Expression of hemoglobin in rodent neurons. J Cereb Blood Flow Metab (2008) 1.26
Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. Neuropsychopharmacology (2007) 1.25
Development and optimization of adeno-associated virus vector transfer into the central nervous system. Methods Mol Med (2003) 1.23
Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin. Am J Pathol (2007) 1.20
Nucleus accumbens mGluR5-associated signaling regulates binge alcohol drinking under drinking-in-the-dark procedures. Alcohol Clin Exp Res (2012) 1.19
AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke (2010) 1.19
Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology (2006) 1.18
Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. J Neurosci (2004) 1.18
Actin/alpha-actinin-dependent transport of AMPA receptors in dendritic spines: role of the PDZ-LIM protein RIL. J Neurosci (2004) 1.17
Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem (2006) 1.16
Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab (2003) 1.13
Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? Front Neurosci (2010) 1.12
Effects of granulocyte-colony stimulating factor after stroke in aged rats. Stroke (2010) 1.11
Nerve terminal nicotinic acetylcholine receptors initiate quantal GABA release from perisomatic interneurons by activating axonal T-type (Cav3) Ca²⁺ channels and Ca²⁺ release from stores. J Neurosci (2011) 1.10
Experimental RNomics in Aquifex aeolicus: identification of small non-coding RNAs and the putative 6S RNA homolog. Nucleic Acids Res (2005) 1.08
CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit. Mol Ther (2010) 1.08
Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function. J Neurosci (2005) 1.08
NAC1 regulates the recruitment of the proteasome complex into dendritic spines. J Neurosci (2007) 1.08
Effects of neural progenitor cells on sensorimotor recovery and endogenous repair mechanisms after photothrombotic stroke. Stroke (2011) 1.07
TorsinA protects against oxidative stress in COS-1 and PC12 cells. Neurosci Lett (2003) 1.06
New targets for established proteins: exploring G-CSF for the treatment of stroke. Trends Pharmacol Sci (2007) 1.04
Toward a multimodal neuroprotective treatment of stroke. Stroke (2006) 1.04
Developing granulocyte-colony stimulating factor for the treatment of stroke: current status of clinical trials. Stroke (2006) 1.04
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res (2006) 1.04
Multifunctional actions of approved and candidate stroke drugs. Neurotherapeutics (2009) 1.03
The role of granulocyte-colony stimulating factor (G-CSF) in the healthy brain: a characterization of G-CSF-deficient mice. J Neurosci (2009) 1.03
The role of CC chemokine receptor 2 on microglia activation and blood-borne cell recruitment after transient focal cerebral ischemia in mice. Brain Res (2009) 1.02
Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time. Stroke (2011) 1.02
New aspects of breast volume measurement using 3-dimensional surface imaging. Ann Plast Surg (2006) 1.01
Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol (2009) 1.01
Granulocyte-colony stimulating factor for stroke treatment: mechanisms of action and efficacy in preclinical studies. Exp Transl Stroke Med (2009) 1.01
Neuronal co-expression of EGFP and beta-galactosidase in mice causes neuropathology and premature death. Neurobiol Dis (2004) 1.00
Glial promoter selectivity following AAV-delivery to the immature brain. PLoS One (2013) 1.00
Optogenetic release of ACh induces rhythmic bursts of perisomatic IPSCs in hippocampus. PLoS One (2011) 0.99
Methodological quality of preclinical stroke studies is not required for publication in high-impact journals. J Cereb Blood Flow Metab (2010) 0.98
Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing. Gastroenterology (2007) 0.98
AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity. PLoS One (2010) 0.98
An extended window of opportunity for G-CSF treatment in cerebral ischemia. BMC Biol (2006) 0.98
Granulocyte-colony stimulating factor (G-CSF) and G-CSF receptor expression in human ischemic stroke. Acta Neuropathol (2006) 0.98
Carbon dioxide versus room air for natural orifice transluminal endoscopic surgery (NOTES) and comparison with standard laparoscopic pneumoperitoneum. Gastrointest Endosc (2010) 0.97